Efficacy and safety of human chorionic gonadotropin for follicular phase stimulation in assisted reproduction: A systematic review and meta-analysis

Fertility and Sterility

Volumn 97, Issue 6, 2012, Pages

  Checa, Miguel A ^a   Espinós, Juan José ^a   Requena, Antonio ^b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b INSTITUTO VALENCIANO DE INFERTILIDAD   (Spain)

Author keywords

controlled ovarian stimulation; follicular maturation; FSH doses; hCG; meta analysis; systematic review

Indexed keywords

CHORIONIC GONADOTROPIN; FOLLITROPIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; HUMAN MENOPAUSAL GONADOTROPIN; PLACEBO; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE;

DRUG EFFICACY; DRUG SAFETY; FEMALE INFERTILITY; FOLLICULAR PHASE; HUMAN; INFERTILITY THERAPY; LIVE BIRTH; META ANALYSIS; OOCYTE MATURATION; OVARY CYCLE; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PREGNANCY RATE; PRIORITY JOURNAL; REVIEW; SPAIN; SPONTANEOUS ABORTION; SYSTEMATIC REVIEW;

EID: 84861631770     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2012.02.049     Document Type: Article

References (28)

1. M. Filicori, A.T. Fazleabas, I. Huhtaniemi, P. Licht, ChV Rao, and J. Tesarik Novel concepts of human chorionic gonadotropin: reproductive system interactions and potential in the management of infertility Fertil Steril 84 2005 275 284
2. J.M. Glanville, C. Lefebvre, J.N. Miles, and J. Camosso-Stefinovic How to identify randomized controlled trials in MEDLINE: ten years on J Med Libr Assoc 94 2006 130 136
3. G. Lowe, and S. Twaddle The Scottish Intercollegiate Guidelines Network (SIGN): an update Scott Med J 50 2005 51 52
4. F. Zegers-Hochschild, K.G. Nygren, G.D. Adamson, J. de Mouzon, P. Lancaster, and R. Mansour The ICMART glossary on ART terminology Hum Reprod 21 2006 1968 1970
5. J.L. Fleiss The statistical basis of meta-analysis Stat Methods Med Res 2 1993 121 145
6. A. Donner, and N. Klar The statistical analysis of kappa statistics in multiple samples J Clin Epidemiol 49 1996 1053 1058
7. P.T. Higgins, and S. Green Cochrane handbook for systematic reviews of interventions 2008 The Cochrane Collaboration and John Wiley & Sons Ltd. Chichester, West Sussex, UK 202-6
8. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses Br Med J 327 2003 557 560
9. P. Beretsos, G.A. Partsinevelos, E. Arabatzi, P. Drakakis, D. Mavrogianni, and E. Anagnostou "hCG priming" effect in controlled ovarian stimulation through a long protocol Reprod Biol Endocrinol 7 2009 91
10. M. Filicori, G.E. Cognigni, S. Taraborrelli, D. Spettoli, W. Ciampaglia, and C. Tabarelli de Fatis Luteinizing hormone activity supplementation enhances follicle-stimulating hormone efficacy and improves ovulation induction outcome J Clin Endocrinol Metab 84 1999 2659 2663
11. K. Lossl, C.Y. Andersen, A. Loft, N.L. Freiesleben, S. Bangsboll, and A.N. Andersen Short-term androgen priming by use of aromatase inhibitor and hCG before controlled ovarian stimulation for IVF. A randomized controlled trial Hum Reprod 23 2008 1820 1829
12. P. Drakakis, D. Loutradis, A. Beloukas, V. Sypsa, V. Anastasiadou, and G. Kalofolias Early hCG addition to rFSH for ovarian stimulation in IVF provides better results and the cDNA copies of the hCG receptor may be an indicator of successful stimulation Reprod Biol Endocrinol 7 2009 110 10.1186/1477-7827-7-110
13. C. Blockeel, M. De Vos, W. Verpoest, D. Stoop, P. Haentjens, and P. Devroey Can 200 IU of hCG replace recombinant FSH in the late follicular phase in a GnRH-antagonist cycle? A pilot study Hum Reprod 24 2009 2910 2916
14. K. Kyono, K. Fuchinoue, Y. Nakajo, A. Yagi, and K. Sasaki A prospective randomized study of three ovulation induction protocols for IVF: GnRH agonist versus antagonist with and without low dose hCG. [Abstract] Fertil Steril 82 Suppl 2 2004 S31
15. M. Filicori, G.E. Cognigni, E. Gamberini, L. Parmegiani, E. Troilo, and B. Roset Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation Fertil Steril 84 2005 394 401
16. P. Serafini, I. Yadid, E.L. Motta, J.R. Alegretti, J. Fioravanti, and M. Coslovsky Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized trial Fertil Steril 86 2006 830 838
17. K. Kyono, Y. Nakajo, S. Kumagai, and S. Sasaki Efficacy of low-dose human chorionic gonadotropin (hCG) in a GnRH antagonist protocol J Assist Reprod Genet 23 2006 223 228
18. M. Gomes, C. Vieira, M. Moura, L. Manetta, S. Leite, and R. Reis Controlled ovarian stimulation with exclusive FSH followed by stimulation with hCG alone, FSH alone or hMG Eur J Obstet Gynecol Reprod Biol 130 2007 99 106
19. R. Dehghani-Firouzabady, M. Asgharnia, N. Tayebi, and S.M. Kalantar Use of low-dose human chorionic gonadotropin (hCG) fore final follicular maturation in ovulatory women treated by intrauterine insemination Middle East Fertil Soc J 11 2006 210 215
20. J.A. Huirne, C.B. Lambalk, A.C. van Loenen, R. Schats, P.G. Hompes, and B.C. Fauser Contemporary pharmacological manipulation in assisted reproduction Drugs 64 2004 297 322
21. Y.A. Chandrasekher, J.S. Hutchison, M.B. Zelinski-Wooten, D.L. Hess, D.P. Wolf, and R.L. Stouffer Initiation of periovulatory events in primate follicles using recombinant and native human luteinizing hormone to mimic the midcycle gonadotropin surge J Clin Endocrinol Metab 79 1994 298 306
22. A. Weissman, S. Lurie, Y. Zalel, R. Goldchmit, and Z. Shoham Human chorionic gonadotropin: pharmacokinetics of subcutaneous administration Gynecol Endocrinol 10 1996 273 276
23. The European Recombinant Human Chorionic Gonadotropin Study Group Induction of final follicular maturation and early luteinization in women undergoing ovulation induction for assisted reproduction treatment - recombinant hCG versus urinary hCG Hum Reprod 15 2000 1446 1451
24. M. Filicori, G.E. Cognigni, P. Pocognoli, C. Tabarelli, D. Spettoli, and S. Taraborrelli Modulation of folliculogenesis and steroidogenesis in women by graded menotrophin administration Hum Reprod 17 2002 2009 2015
25. J. Balasch, and F. Fábregues LH in the follicular phase: neither too high nor too low Reprod Biomed Online 12 2006 406 415
26. P. Platteau, A.N. Andersen, A. Balen, P. Devroey, P. Sorensen, and L. Helmgaard Similar ovulation rates, but different follicular development with highly purified menotrophin compared with recombinant FSH in WHO Group II anovulatory infertility: a randomized controlled study Hum Reprod 21 2006 1798 1804
27. S. Ziebe, K. Lundin, R. Janssens, L. Helmgaard, and J.C. Arce Influence of ovarian stimulation with HP-hMG or recombinant FSH on embryo quality parameters in patients undergoing IVF Hum Reprod 22 2007 2404 2413
28. D. Bodri, J.J. Guillén, M. Trullenque, K. Schwenn, C. Esteve, and O. Coll Early ovarian hyperstimulation syndrome is completely prevented by gonadotropin releasing-hormone agonist triggering in high-risk oocyte donor cycles: a prospective, luteal-phase follow-up study Fertil Steril 93 2010 2418 2420